Skip to main content
Top

Reactions Weekly

Issue 1/2013

March 23, 2013

Content (123 Articles)

Case report

Afatinib

Case report

Alteplase

Case report

Adalimumab/etanercept

Case report

Adalimumab

Case report

Amlodipine

Case report

Anakinra

Case report

Antirheumatics

Case report

Antineoplastics

Case report

Antiretrovirals

Case report

Antiretrovirals

Case report

Arsenic trioxide

Case report

Aspirin/clopidogrel

Case report

Atosiban

Case report

Bisphosphonates

Case report

Bortezomib

Case report

Botulinum toxin A

Case report

Calcium gluconate

Case report

Butamirate

Case report

Capecitabine

Case report

Ceftriaxone

Case report

Chlorhexidine

Case report

Clozapine withdrawal

Case report

Chlorphenamine

Case report

Dabigatran etexilate

Case report

Dabigatran etexilate

Case report

Dexamethasone

Case report

Didanosine

Case report

Epoprostenol

Case report

Doxylamine overdose

Case report

Dronedarone

Case report

Ethambutol

Case report

Erlotinib

Case report

Erlotinib

Case report

Flecainide

Case report

Fluoxetine

Case report

Hydroxycarbamide

Case report

Heparin

Case report

Immune globulin

Case report

Imiquimod

Case report

Immunosuppressants

Case report

Indometacin

Case report

Infliximab

Case report

Infliximab

Case report

Insulin aspart

Case report

Levamisole

Case report

Lacosamide

Case report

Lubiprostone

Case report

Methotrexate

Case report

Methyldopa

Case report

Natalizumab

Case report

Olanzapine

Case report

Opioids

Case report

Prednisolone

Case report

Risperidone

Case report

Pregabalin

Case report

Risperidone

Case report

Ritodrine

Case report

Rituximab

Case report

Rituximab

Case report

Ritodrine

Case report

Sitagliptin

Case report

Sulphan blue

Case report

Rufinamide

Case report

Sunitinib

Case report

Sunitinib

Case report

Sunitinib

Case report

Tacrolimus

Case report

Tranexamic acid

Case report

Trastuzumab

Case report

Vemurafenib

Case report

Ustekinumab

Case report

Warfarin